Summary
- In a lengthy reasoned judgment in the case of re Yangtze River Pharma et al. v HIPI Pharma, the Supreme People's Court ruled on three IP-related or novel antitrust
A Vital Supreme People's Court Decision for IP Rights Holders in China
Wei Huang, Wendy Zhou and Lujia Yu, antitrust specialists at Beijing Tian Yuan Law Firm, examine the landmark Supreme People's Court judgment in re Yangtze River Pharma et al. v HIPI Pharma et al
By
Susan Mok